Stock listing
NASDAQ:CMRX Chimerix Inc Stock
Follow Chimerix Inc into a list and get an email when it puts out news.
Last close · NASDAQ:CMRX
$8.54 USD
Close on Apr 17, 2025 · No longer trades
- Lowest – highest close
- $0.771 – $57.43 USDSince Apr 11, 2013 · lowest Aug 13, 2024 · highest Aug 5, 2015
Delisted NASDAQ:CMRX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:CMRX
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Chimerix Inc on 6ix
- Calls
- 16 calls with a replay · 16 with a transcript · latest Nov 7, 2024
- Decks
- 17 decks · latest Dec 10, 2024
Events
| Call | When | Status |
|---|---|---|
| Chimerix (CMRX) Q3 2024 Earnings Call | Thu, Nov 07, 2024 · 8:30 AM ET | Replay |
| Chimerix (CMRX) Q2 2024 Earnings Call | Tue, Aug 13, 2024 · 8:30 AM ET | Replay |
| Chimerix (CMRX) Q1 2024 Earnings Call | Wed, May 01, 2024 · 8:30 AM ET | Replay |
| Chimerix (CMRX) Q4 2023 Earnings Call | Thu, Feb 29, 2024 · 8:30 AM ET | Replay |
| Chimerix (CMRX) Q3 2023 Earnings Call | Thu, Nov 02, 2023 · 8:30 AM ET | Replay |
| Chimerix (CMRX) Q2 2023 Earnings Call | Thu, Aug 03, 2023 · 8:30 AM ET | Replay |
| Chimerix (CMRX) Q1 2023 Earnings Call | Thu, May 04, 2023 · 8:30 AM ET | Replay |
| Chimerix (CMRX) Q4 2022 Earnings Call | Thu, Mar 02, 2023 · 8:30 AM ET | Replay |
| Chimerix (CMRX) Q3 2022 Earnings Call | Thu, Nov 03, 2022 · 8:30 AM ET | Replay |
| Chimerix (CMRX) Q2 2022 Earnings Call | Mon, Aug 08, 2022 · 4:30 PM ET | Replay |
All 16 calls
| Call | When | Status |
|---|---|---|
| Chimerix (CMRX) Q1 2022 Earnings Call | Mon, May 16, 2022 · 8:30 AM ET | Replay |
| Chimerix (CMRX) Q4 2021 Earnings Call | Tue, Mar 01, 2022 · 8:30 AM ET | Replay |
| Chimerix (CMRX) Q3 2021 Earnings Call | Thu, Nov 04, 2021 · 8:30 AM ET | Replay |
| Chimerix (CMRX) Q2 2021 Earnings Call | Thu, Aug 05, 2021 · 8:30 AM ET | Replay |
| Chimerix (CMRX) Q1 2021 Earnings Call | Thu, May 06, 2021 · 8:30 AM ET | Replay |
| Chimerix (CMRX) Q4 2020 Earnings Call | Thu, Feb 25, 2021 · 8:30 AM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (December 2024) | Investor deck | 39 slides | Dec 10, 2024 |
| Investor Presentation (November 2024) | Investor deck | 35 slides | Nov 7, 2024 |
| Investor Presentation (August 2024) | Investor deck | 35 slides | Aug 13, 2024 |
| Investor Presentation (May 2024) | Investor deck | 29 slides | May 1, 2024 |
| Investor Presentation (February 2024) | Investor deck | 29 slides | Feb 29, 2024 |
| Investor Presentation (November 2023) | Investor deck | 42 slides | Nov 2, 2023 |
| Investor Presentation (August 2023) | Investor deck | 43 slides | Aug 3, 2023 |
| Investor Presentation (May 2023) | Investor deck | 41 slides | May 4, 2023 |
| Investor Presentation (March 2023) | Investor deck | 38 slides | Mar 2, 2023 |
| 41st Annual J.P. Morgan Healthcare Conference (January 2023) | Conference | 20 slides | Jan 12, 2023 |
All 17 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (December 2022) | Investor deck | 34 slides | Dec 9, 2022 |
| Corporate Update (November 2021) | Corporate update | 32 slides | Nov 22, 2021 |
| Merger or Acquisition (January 2021) | Merger or acquisition | 26 slides | Jan 8, 2021 |
| Cowen Healthcare Conference 2019 | Conference | 20 slides | Mar 11, 2019 |
| J.P. Morgan Healthcare Conference 2018 | Conference | 25 slides | Jan 10, 2018 |
| Investor Presentation (November 2017) | Investor deck | 50 slides | Nov 14, 2017 |
| Investor Presentation (January 2017) | Investor deck | 29 slides | Jan 6, 2017 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Patrick Machado Other companies: Alumis Inc. (Independent Board Member · Since at least Jun 27, 2024); Xenon Pharmaceuticals Inc. (Director · Since at least Nov 5, 2020); Arcus Biosciences, Inc. (Board Member · Since at least Dec 10, 2019); Adverum Biotechnologies Inc (Director · Since at least Mar 14, 2017); Turnstone Biologics Corp. (Director · Jul 20, 2023 – Jul 20, 2023 · Past); Acelyrin, Inc. (Director · May 4, 2023 – May 21, 2025 · Past); Roivant Sciences Ltd. (Director · Oct 1, 2021 – Oct 1, 2021 · Past); Principia Biopharma Inc (Director · Jun 11, 2019 – Sep 28, 2020 · Past); Turning Point Therapeutics Inc (Director · May 13, 2019 – Aug 17, 2022 · Past); Endocyte Inc (Director · Feb 27, 2018 – Dec 21, 2018 · Past); Sio Gene Therapies Inc (Director · Jul 17, 2017 – Jul 17, 2017 · Past); Rocket Pharmaceuticals, Inc. (Director · Aug 17, 2016 – Jun 20, 2017 · Past); Scynexis, Inc. (Director · Sep 24, 2015 – Jan 2, 2019 · Past); Medivation Inc (Director · Jun 5, 2007 – Sep 28, 2016 · Past) | Director · Jun 20, 2014 – Jun 9, 2023 · Past |
| Fred A Middleton Other companies: CalciMedica, Inc. (Director · Since at least Mar 20, 2023); Stereotaxis, Inc. (Director · Jan 3, 2012 – Mar 2, 2018 · Past); Endocyte Inc (Director · Dec 16, 2011 – Dec 21, 2018 · Past); Pacira BioSciences, Inc. (Director · Nov 21, 2011 – Jun 21, 2013 · Past) | Director · Mar 28, 2018 – Apr 21, 2025 · Past |
| Martha Demski Other companies: Alpha Teknova, Inc. (Board Member · Since at least Aug 31, 2023); Equillium, Inc. (Director · Since at least May 24, 2022); ADMA Biologics Inc (Director · Mar 6, 2023 – Mar 6, 2023 · Past) | Director · May 17, 2022 – Apr 21, 2025 · Past |
| Michael Sherman Other companies: Aktis Oncology, Inc. (Director · Since at least Jan 8, 2026); Werewolf Therapeutics, Inc. (Director · Since at least May 24, 2024) | Chief Executive Officer, Director · Jun 20, 2024 – Apr 21, 2025 · Past |
| Victoria Vakiener Other companies: Arrowhead Pharmaceuticals, Inc. (Director · Since at least May 2, 2022); Epizyme Inc (Chief Commercial Officer · Sep 18, 2020 – Feb 4, 2021 · Past) | Director · Apr 22, 2021 – Apr 21, 2025 · Past |
| Lisa Lynn Decker Other companies: IGM Biosciences Inc (CHIEF BUSINESS OFFICER · Since at least Jun 16, 2025) | Director · Apr 21, 2025 – Apr 21, 2025 · Past |
| Michael T Andriole Other companies: Endocyte Inc (Chief Financial Officer · Oct 4, 2017 – Dec 21, 2018 · Past) | PRESIDENT AND CEO, Director · Apr 8, 2019 – Apr 21, 2025 · Past |
| Robert J. Meyer Other companies: Avalyn Pharma Inc. (Director · Since at least Sep 15, 2026) | Director · Jun 20, 2024 – Apr 21, 2025 · Past |
| W. Garrett Nichols Other companies: Candel Therapeutics, Inc. (Chief Medical Officer · Since at least Sep 12, 2022) | Chief Medical Officer · Sep 2, 2014 – Feb 7, 2020 · Past |
| Allen S Melemed | CHIEF MEDICAL OFFICER · Apr 21, 2025 – Apr 21, 2025 · Past |
All 16 people
| Person | Seat |
|---|---|
| Catherine Gilliss | Director · Jun 23, 2022 – Jun 9, 2023 · Past |
| David Jakeman | VP OF FINANCE AND ACCOUNTING · Jun 20, 2019 – Apr 21, 2025 · Past |
| Michael Albert Alrutz | SVP AND GENERAL COUNSEL · Feb 5, 2019 – Apr 21, 2025 · Past |
| Thomas J Riga | COO and CCO · Apr 21, 2025 – Apr 21, 2025 · Past |
| Timothy Wollaeger | Director · Apr 10, 2013 – Mar 2, 2016 · Past |
| Wende S Hutton | Director · Apr 10, 2013 – Oct 23, 2013 · Past |
Log in to ask 6ix AI your own questions about Chimerix Inc.